131 related articles for article (PubMed ID: 4409591)
1. [Follow-up studies on malignant melanomas after endolymphatic radionuclide therapy].
Gehring D; Baumeister L
Med Welt; 1974 Jun; 25(23):1045-7. PubMed ID: 4409591
[No Abstract] [Full Text] [Related]
2. [Radiation-dosimetry studies after endolymphatic radionuclide therapy].
Pfannenstiel P
Med Welt; 1974 Jun; 25(23):1038-42. PubMed ID: 4369658
[No Abstract] [Full Text] [Related]
3. [Tabular and case demonstrations of 100 malignant melanomas treated by endolymphatic therapy].
Makoski HB; Scherer E
Med Welt; 1974 Jun; 25(23):1042-4. PubMed ID: 4605981
[No Abstract] [Full Text] [Related]
4. [Study group--endolymphatic radionuclide therapy].
Peters PE
Med Welt; 1974 Jun; 25(23):1056-8. PubMed ID: 4411008
[No Abstract] [Full Text] [Related]
5. [Clinical results of endolymphatic radionuclide therapy in the treatment of malignant melanoma].
Makoski HB; Magnus L; Heissen E; Kolpatzik H; Drepper H
Strahlentherapie; 1974 Jul; 148(1):1-15. PubMed ID: 4612879
[No Abstract] [Full Text] [Related]
6. [Results of lymphographic course controls following endolymphatic radionuclide therapy].
Wolf G
Med Welt; 1974 Jun; 25(23):1050-4. PubMed ID: 4410764
[No Abstract] [Full Text] [Related]
7. [Endolymphatic radionuclide adjuvant therapy of melanoma and its side effects on the cellular immune system].
Richter G; Heidenbluth I; Heidelbach U
Dermatol Monatsschr; 1982 Dec; 168(12):797-806. PubMed ID: 7169101
[No Abstract] [Full Text] [Related]
8. [Endolymphatic radionuclide therapy of the malignant melanoma (author's transl)].
Makoski HB; Scherer E; Magnus L; Verbeek W
Strahlentherapie; 1978 Mar; 154(3):169-73. PubMed ID: 635942
[TBL] [Abstract][Full Text] [Related]
9. [Examination technic and monitoring of patients in endolymphatic radionuclide therapy].
Peters PE
Med Welt; 1974 Jun; 25(23):1031-5. PubMed ID: 4409524
[No Abstract] [Full Text] [Related]
10. [Close radiotherapy of neoplastic diseases of the skin].
Pereslegin IA; Merman AM; Abramov VF
Med Radiol (Mosk); 1971 Jul; 16(7):7-11. PubMed ID: 5147385
[No Abstract] [Full Text] [Related]
11. [Follow-up studies in endolymphatic radioisotope therapy].
Wolf G
Strahlentherapie; 1971 Sep; 142(3):269-75. PubMed ID: 5118494
[No Abstract] [Full Text] [Related]
12. [Indications, contraindications and adverse effects of endolymphatic radionuclide therapy].
Weissleder H
Med Welt; 1974 Jun; 25(23):1028-31. PubMed ID: 4409831
[No Abstract] [Full Text] [Related]
13. Intralymphatic isotope therapy.
Jantet G
Cancro; 1971; 24(6):327-36. PubMed ID: 5173462
[No Abstract] [Full Text] [Related]
14. [Indications for and borderlines of endolymphatic therapy of melanoma and seminoma].
Kärcher KH; Messeritsch M; Bardach G; Seitz W; Wolf G
Strahlentherapie Sonderb; 1972; 72():261-72. PubMed ID: 4659340
[No Abstract] [Full Text] [Related]
15. [Therapy of endolymphatic metastastases in malignant melanoma using radioisotopes].
Weissleder H; Pfannenstiel P
Arch Dermatol Forsch; 1972; 244():245-50. PubMed ID: 4648699
[No Abstract] [Full Text] [Related]
16. [Radiation dose to the lung following endolymphatic radionuclide therapy of melanoma of the lower limbs].
Müller RP; Peters PE
Strahlentherapie; 1985 Jan; 161(1):23-9. PubMed ID: 2982221
[TBL] [Abstract][Full Text] [Related]
17. [Endolymphatic lipiodol-P32 therapy in melanoma of the limbs during clinical stage 1].
Kokoschka E
Med Welt; 1974 Jun; 25(23):1054-5. PubMed ID: 4369551
[No Abstract] [Full Text] [Related]
18. [Problems in the radiological treatment of malignant melanomas of the skin. Report on 136 patients followed-up over long period of time].
Koenig H
Z Arztl Fortbild (Jena); 1970 Aug; 64(15):770-9. PubMed ID: 5523013
[No Abstract] [Full Text] [Related]
19. [Therapy of malignant melanoma].
Stein G
Fortschr Med; 1975 Aug; 93(22-23):1060-5. PubMed ID: 1225789
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of skin tumors with a pulse laser].
Gamaleia NF; Polishchuk EI
Vopr Onkol; 1978; 24(1):76-81. PubMed ID: 636374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
